Us Bancorp »

Revance Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 2.4k 8.79
2023-09-30 $38k 3.3k 11.47
2023-06-30 $81k 3.2k 25.31
2023-03-31 $128k 4.0k 32.21
2022-12-31 $487k 26k 18.46
2022-09-30 $458k 17k 26.96
2022-06-30 $12k 852 14.08
2022-03-31 $41k 2.1k 19.47
2021-12-31 $41k 2.5k 16.20
2021-09-30 $8.0k 275 29.09
2021-06-30 $8.0k 275 29.09
2021-03-31 $8.0k 275 29.09
2020-12-31 $7.0k 257 27.24
2020-09-30 $6.0k 257 23.35
2020-06-30 $6.0k 257 23.35
2020-03-31 $3.0k 198 15.15
2019-12-31 $3.0k 198 15.15
2019-09-30 $11k 743 15.15
2019-06-30 $7.0k 545 12.84
2019-03-31 $12k 673 17.34
2018-12-31 $10k 500 20.00
2018-09-30 $19k 760 25.00
2018-06-30 $21k 760 27.63
2018-03-31 $15k 500 30.00